CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CRL currently has 49M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 0.13% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 49.0M shares outstanding |
49M | 0 |
| Nov 05, 2025 |
10-Q filing | 49.2M shares outstanding |
49M | 0 |
| Aug 06, 2025 |
10-Q filing | 49.1M shares outstanding |
49M | 0 |
| May 07, 2025 |
10-Q filing | 50.7M shares outstanding |
51M | 0 |
| Feb 21, 2025 |
8-K filing: Mr. James C. Foster, Chair, President and Chief Executive Officer, purchased 6,075 shares of the Company's common stock at an average price of $165.01, and Ms. Birgit Girshick, Corporate Executive Vice President and Chief Operating Officer, purchased 1,514 shares of the Company's common stock at an average price of $164.63. ($1.25M proceeds) |
51M | 0 |
| Feb 19, 2025 |
10-K filing | 51.4M shares outstanding |
51M | 0 |
| Nov 06, 2024 |
10-Q filing | 51.4M shares outstanding |
51M | 0 |
| Aug 07, 2024 |
10-Q filing | 51.6M shares outstanding |
52M | 0 |
| May 09, 2024 |
10-Q filing | 51.4M shares outstanding |
51M | 0 |
| Feb 14, 2024 |
10-K filing | 51.5M shares outstanding |
51M | 0 |
| Nov 15, 2023 |
8-K filing: On November 14, 2023, Mr. James C. Foster, Chair, President and Chief Executive Officer of Charles River Laboratories International, Inc., purchased 5,620 shares of the Company's common stock at an average price of $178.05 for an aggregate purchase price of approximately $1.0 million in open market transactions. ($1.0M proceeds) |
51M | 0 |
| Nov 08, 2023 |
10-Q filing | 51.3M shares outstanding |
51M | 0 |
| Aug 09, 2023 |
10-Q filing | 51.2M shares outstanding |
51M | 0 |
| May 11, 2023 |
10-Q filing | 51.1M shares outstanding |
51M | 0 |
| Feb 22, 2023 |
10-K filing | 50.8M shares outstanding |
51M | 0 |
| Nov 02, 2022 |
10-Q filing | 50.9M shares outstanding |
51M | 0 |
| Aug 03, 2022 |
10-Q filing | 50.8M shares outstanding |
51M | 0 |
| May 04, 2022 |
10-Q filing | 50.6M shares outstanding |
51M | 0 |
| Feb 16, 2022 |
10-K filing | 50.3M shares outstanding |
50M | 0 |
| Nov 03, 2021 |
10-Q filing | 50.4M shares outstanding |
50M | 0 |
| Aug 04, 2021 |
10-Q filing | 50.3M shares outstanding |
50M | 0 |
| May 04, 2021 |
10-Q filing | 50.0M shares outstanding |
50M | 0 |
| Feb 17, 2021 |
10-K filing | 49.6M shares outstanding |
50M | 0 |
| Oct 29, 2020 |
10-Q filing | 49.7M shares outstanding |
50M | 0 |
| Aug 05, 2020 |
10-Q filing | 49.6M shares outstanding |
50M | 0 |
| May 07, 2020 |
10-Q filing | 49.2M shares outstanding |
49M | 0 |
| Feb 11, 2020 |
10-K filing | 48.7M shares outstanding |
49M | 0 |